Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$70.8M
+51.0% from 2023
Prescriptions
97K
$728.42 per claim
Patients
27K
13,797 prescribers
Total spending, 2024
$70.8M
$2,608.74 per patient
Medicare prescription drug plans paid $70.8M for Nexlizet in 2024, for 97,188 prescriptions and refills to 27,136 patients (up 51.0% from 2023). The average cost per claim was $728.42.
California had the highest Medicare cost for Nexlizet in 2024: $8.9M for 13,928 claims, followed by New York ($6.9M).
Don W Lee, interventional cardiology in Glendale, CA, had the highest Medicare cost for Nexlizet in 2024: 881 claims costing $416K.
Nexlizet is made by Esperion Therapeutics, Inc. (ESPR), listed in the Medicare spending data as Esperion Therap.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Don W Lee Glendale, CA | Interventional Cardiology | 881 | 160 | $416K |
| Wu Tan Flushing, NY | Internal Medicine | 500 | 92 | $231K |
| Yili Huang Elmhurst, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 6,357 | 44,681 | 11,465 | $30.5M |
| 2023 | 9,039 | 63,591 | 16,669 | $46.9M |
| 2024 | 13,797 | 97,188 | 27,136 | $70.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 452 |
| 93 |
| $214K |
| Jivan Melikian Glendale, CA | Cardiology | 462 | 66 | $204K |
| Henry C Yee Alhambra, CA | Cardiology | 322 | 79 | $193K |
| Afshine A Emrani Tarzana, CA | Cardiology | 312 | 64 | $186K |
| Avichai Eres Lexington, KY | Cardiology | 218 | 67 | $178K |
| John C Isaac Houston, TX | Cardiology | 181 | 51 | $169K |
| Jonathan S Lown Commack, NY | Internal Medicine | 174 | 47 | $161K |
| Amy D Kingman Macon, GA | Cardiology | 159 | 44 | $157K |
| John R Nelson Fresno, CA | Cardiology | 177 | 51 | $154K |
| Eliscer Guzman New York, NY | Internal Medicine | 221 | 63 | $137K |
| Frank G Romascavage Brodheadsville, PA | General Practice | 232 | 45 | $135K |
| Michael Flores Lynwood, CA | Physician Assistant | 321 | 75 | $135K |
| Homayoun Sharim Beverly Hills, CA | Internal Medicine | 310 | 46 | $132K |
| Richard Khalil Yonkers, NY | Family Practice | 201 | 68 | $121K |
| Anthony D Alfieri Newark, DE | Cardiology | 115 | 40 | $120K |
| Singh A Boun Monterey Park, CA | Family Practice | 251 | 47 | $120K |
| Nagavardhan Vasuki Wellington, FL | Cardiology | 146 | 42 | $116K |
| William H Skinner Lexington, KY | Cardiology | 127 | 33 | $112K |
| Matvey Brokhin Brooklyn, NY | Endocrinology | 215 | 41 | $109K |
| Weston C Hickey Houston, TX | Interventional Cardiology | 146 | 37 | $108K |
| Khalid Abousy Manassas, VA | Interventional Cardiology | 118 | 31 | $106K |
| Murray I Wellner West Hartford, CT | Internal Medicine | 115 | 30 | $100K |
| Evan D Sehgal Hasbrouck Heights, NJ | Interventional Cardiology | 111 | 30 | $99K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Esperion Therap ESPR | 97,223 | $70.8M |